Market Size and Overview The Acute Myeloid Leukemia (AML) Market is estimated to be valued at USD 1.74 billion in 2026 and is expected to reach USD 2.92 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.7% from 2026 to 2033. https://logcla.com/blogs/1170550/Acute-Myeloid-Leukemia-Market-Growth-Driven-by-Innovative-Therapies